| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1904706bf8e97fa833b047dc1813551e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6aace8dadf09214e538bc0250bbdbb09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_434eb3ac4c8c8aee9a9bd513df6838a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_656bc29e5c9f96c0e7fbc0531e5e43ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee4cae116a056cbad35b70d749c11461
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5354ac86baeb4939ccb57772bc91c9e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D515-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-42 |
| filingDate |
2009-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_695e898ace128cd54eea3016f58690db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ba69b06b9eb30e112413a21cccc9c55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e0e5c5d74b73e4b10a73d395d50e53d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2561bfdc442205b55318a700f7bd81fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeef42210312b580be363371f28ea2b1 |
| publicationDate |
2013-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8501767-B2 |
| titleOfInvention |
Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors |
| abstract |
The invention provides compounds of formula A or B which are useful in the treatment of a subject infected with HIV. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11098043-B2 |
| priorityDate |
2008-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |